Short answer · Medically reviewed summary · Last updated: 2026-04-07
Nail-patella syndrome (NPS), also known as hereditary osteo-onychodysplasia, is a rare genetic disorder characterized by abnormalities of the nails, knees, elbows, and pelvis. It primarily affects the skeletal and renal systems, often leading to distinct physical features and a lifelong risk of kidney disease. What are the key clinical features of Nail-patella syndrome? Nail-patella syndrome affects multiple body systems, most notably the skeletal structure.
Nail-patella syndrome (NPS), also known as hereditary osteo-onychodysplasia, is a rare genetic disorder characterized by abnormalities of the nails, knees, elbows, and pelvis. It primarily affects the skeletal and renal systems, often leading to distinct physical features and a lifelong risk of kidney disease.
Nail-patella syndrome affects multiple body systems, most notably the skeletal structure. The hallmark signs include absent or underdeveloped kneecaps (patellae), which can cause joint instability. Fingernails and toenails are often hypoplastic (underdeveloped), split, or discolored, particularly on the thumbs. Additionally, many individuals with Nail-patella syndrome develop "iliac horns," which are small, bony projections on the pelvic bone that are often detected via X-ray. Elbow involvement, such as a limited range of motion or dislocation of the radial head, is also common.
While the skeletal changes are the most visible, the internal impact of Nail-patella syndrome is medically significant. Approximately 30% to 50% of affected individuals experience renal (kidney) involvement. This typically manifests as the leakage of protein into the urine (proteinuria) or blood in the urine (hematuria). Over time, some patients may progress to chronic kidney disease or end-stage renal disease, which is why routine monitoring is essential. Other systemic manifestations may include glaucoma or ocular hypertension, which occur at a higher frequency in patients with Nail-patella syndrome compared to the general population.
Nail-patella syndrome is caused by a mutation in the LMX1B gene, which provides instructions for making a protein essential for the development of limbs and kidneys during fetal growth. It is inherited in an autosomal dominant pattern, meaning an affected parent has a 50% chance of passing the condition to each child. Because it is a genetic condition, symptoms are present from birth, although their severity can vary significantly even within the same family.
Nail-patella syndrome is considered a rare disease, with an estimated prevalence of approximately 1 in 50,000 individuals worldwide. There is no known predilection for specific geographic regions or ethnic groups, and it affects males and females equally. Within the DiseaseMaps.org community, 413 people with Nail-patella syndrome have joined to share their experiences, reflecting the global reach of this rare condition.
Diagnosis is usually based on clinical findings and confirmed through genetic testing. Key diagnostic indicators include:
Medical Disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.